ARRDC3 and invasive breast carcinoma: In invasive breast cancer, the loss of ARRDC3 expression results in diminished PAR1 degradation and aberrant signaling (20), whereas ectopic expression of ARRDC3 restores PAR1 endo-lysosomal trafficking and suppresses signaling, invasion, and metastasis (20, 21).